Cargando…
Prognostic factors and predictors of postoperative adjuvant transcatheter arterial chemoembolization benefit in patients with resected hepatocellular carcinoma
BACKGROUND: Postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) has improved overall survival (OS) in patients with hepatocellular carcinoma (HCC). However, the prognostic and predictive factors remain unclear. AIM: To assess the prognostic factors and the predictors of PA-TACE...
Autores principales: | Chen, Ming-Yu, Juengpanich, Sarun, Hu, Jia-Hao, Topatana, Win, Cao, Jia-Sheng, Tong, Chen-Hao, Lin, Jian, Cai, Xiu-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081004/ https://www.ncbi.nlm.nih.gov/pubmed/32205995 http://dx.doi.org/10.3748/wjg.v26.i10.1042 |
Ejemplares similares
-
Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion
por: Ye, Jia-Zhou, et al.
Publicado: (2017) -
Clinical efficacy of gemcitabine and cisplatin-based transcatheter arterial chemoembolization combined with radiotherapy in hilar cholangiocarcinoma
por: Zheng, Wen-Heng, et al.
Publicado: (2019) -
Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
por: Lei, Xue-Fen, et al.
Publicado: (2018) -
Early prediction of survival in hepatocellular carcinoma patients treated with transarterial chemoembolization plus sorafenib
por: Meng, Xiao-Chun, et al.
Publicado: (2018) -
Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma
por: Liu, Chen, et al.
Publicado: (2016)